Topical photodynamic therapy in the treatment of basal cell carcinoma in Singaporean Chinese patients.
Indian J Dermatol Venereol Leprol
;
2015 Mar-Apr; 81(2): 151-154
Article
in English
| IMSEAR
| ID: sea-158264
ABSTRACT
Background:
Topical photodynamic therapy has been used for the treatment of superfi cial and nodular basal cell carcinomas, with varying cure rates.Aims:
This study aims to evaluate the effectiveness of topical photodynamic therapy in the treatment of superfi cial and nodular basal cell carcinomas in Asian patients treated at the National Skin Centre, Singapore. Materials andMethods:
A retrospective analysis of Asian patients with histologically confi rmed basal cell carcinomas and treated with photodynamic therapy was performed.Results:
Eight Chinese patients, with an equal gender distribution and mean age of 83.4 years were included. Five of eight basal cell carcinomas were superficial while the remaining three were nodular. The basal cell carcinomas were located in the head and neck in seven patients. The overall clearance rate at 3 months was 87.5% while the clearance rate for superfi cial and nodular basal cell carcinomas was 100% and 66.6% respectively at 3 months. At 12 months, the overall clearance rate was 85. 7%.Limitations:
This is a retrospective analysis with small patient numbers.Conclusions:
In this small series of eight Asian patients, topical photodynamic therapy has been shown to be effective and generally well-tolerated in the treatment of basal cell carcinomas, particularly of the superfi cial subtype. However, larger studies are needed to evaluate its overall efficacy in Asian patients.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Photochemotherapy
/
Singapore
/
Aged, 80 and over
/
Aged
/
Female
/
Humans
/
Male
/
Carcinoma, Basal Cell
/
Retrospective Studies
/
Administration, Topical
Type of study:
Observational study
Limits:
Aged80
Country/Region as subject:
Asia
Language:
English
Journal:
Indian J Dermatol Venereol Leprol
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS